Novocure’s device for treating brain metastases rejected by FDA

Coverage, in order

1. 1d ago
   
   first Medical Device Network UK indie

   Novocure’s device for treating brain metastases rejected by FDA

   Novocure's Optune Mya uses the company's TTFields therapy, designed to exert physical forces on the electrically charged components of dividing cancer cells, resulting in cell death.

2. 1d ago
   Life Science Sweden Sweden indie

   FDA turns down Novocure’s brain metastases device

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.